Furthermore, stratified analysis indicated that the rs11655237T allele carriers were associated with increas</span>ed neuroblastoma risk for patients with tumor originating from the adrenal gland (adjusted OR =1.51, 95% CI =1.06-2.14, <i>P</i>=0.021) and International Neuroblastoma Staging System (INSS) stage IV disease (adjusted OR =1.60, 95% CI =1.12-2.30, <i>P</i>=0.011).